OBIO

Delighted to attend the Schmidt Science Fellows Interdisciplinary Science Showcase featuring brilliant minds from top universities including my alma mater University of Cambridge.

We are excited to announce the recent expansion of our new API manufacturing facility 📢 🧪Expansion Highlights: -the expansion adds 15,000 sq ft of GMP processing and warehousing space -2 x 2000 L glass-lined reactors added to our existing portfolio to support the scale-up chemical processes -solvent storage capacity increased with cold storage down to -80°C -the API plant is supported with a sampling room, drying room, flow through wash-up & equipment storage, plus warehouse storage shipping/receiving 🏢 GMP manufacturing suites: -the facility is designed to handle up to Safebridge Category 3 compounds, and includes two Hastelloy filter dryers.  -the reactors can support cryogenic (-700C) reactions, hydrogenation reactions and reactions up to 200°C Thank you to our Eurofins CDMO Alphora Inc. community for enabling our continued growth, and to all our current and prospective partners for continuing to entrust our team with your important work Learn more 👉 https://lnkd.in/d8HzwP2U Eurofins CDMO Alphora Inc. Geoff Evans Cheryl A. Young Rob Jordan Marco DiBello, P. Eng. #eurofins #cdmo #smallmolecules #API #expansion #biotech #LabExpansion #milestone

Don't miss the finale of our Life Sciences Breakfast Series on August 20, featuring regenerative medicine pioneers Dr. Michael May (CCRM), Mitchel Sivilotti (OmniaBio), and Dr. Maura Campbell (OBIO). Dr. May will explore the economic and health impacts of regenerative medicine, Sivilotti will discuss collaborative innovation, and Dr. Campbell will moderate a candid conversation on Toronto's future as a global biotech hub. With more speakers to be announced, this event offers unique insights into industry trends, innovation, and commercialization challenges. Network with key players driving Toronto's life sciences sector and be part of shaping the future of medicine. Reserve your seat now: https://lnkd.in/gSSZRuqg

AbbVie, en partenariat avec l’Ontario Bioscience Innovation Organization (OBIO), organise une journée de collaboration le 26 septembre à Toronto. Cet événement rassemblera des chercheurs, des entrepreneurs et des entreprises biotechnologiques du Canada.   Au programme :   🌟 Matinée : Sessions de partenariat individuelles avec les entreprises présélectionnées.   🚀 Après-midi : Conférence d’AbbVie   👉 Exploration des stratégies et des priorités externes d’AbbVie en matière d’innovation 👉 La vision du partenariat selon AbbVie 👉 Cocktail de networking   Pour vous inscrire, cliquez sur le lien ci-dessous 👇   https://lnkd.in/g6qaKyHt     ----   AbbVie, in collaboration with Ontario Bioscience Innovation Organization (OBIO) will host a Partnering Day in Toronto, bringing together researchers, entrepreneurs and biotech companies from Canada on September 26, 2024.   Agenda:   🌟 Morning: One-on-one partnering meetings with pre-selected companies   🚀Afternoon: AbbVie Showcase   👉 Overview of AbbVie’s strategies and external innovation priorities 👉 AbbVie’s approach to partnering 👉 Networking reception   To register, click on the link below. 👇   https://lnkd.in/g6qaKyHt

I am excited to share this op-ed, co-authored by Dr. P.J. Devereaux, of Accelerating Clinical Trials – Accélérer les Essais Cliniques, and I. The availability of clinical trials is not just important for advancing medical research and innovations, it is often a lifeline for patients with severe health conditions who have run out of options for treatment. Here in Canada, we must ensure patients are no longer forced to make desperate choices because they do not have access to the latest trials on home soil. In this op-ed, we discuss the systemic challenges that limit access to clinical trials in Canada and propose actionable solutions. From funding top-ups to a streamlined approval process and enhanced public awareness, there are several steps we can take to ensure no Canadian is deprived of treatment that has the potential to give them a second chance at life. Read the full article here: https://lnkd.in/eTbgbtAC Share it amongst your network so we can raise awareness about the way in which we can transform healthcare outcomes for all Canadians. Innovative Medicines Canada - Médicaments novateurs Canada